go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Delaware rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

How much does Indium In-111 Ibritumomab Tiuxetan, Diagnostic cost?

$2,754

Typical negotiated rate. In Delaware, July 2026.

Insurers have agreed to pay about $2,754 for this service. Most negotiated rates run $2,512 to $3,548.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 3 insurance carriers under federal price transparency rules.

How much rates vary

Professionalmedian $2,754 · 10th to 90th $2,512 to $3,548
$5.0K$10.0Kprofessional $2,754

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,511.89
Median
$2,754.23
Typical High
$3,548.13
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
United
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$4,168.69
Typical High
$6,309.57

Where Delaware sits

The same service costs 3.3 times more in Alaska than in Colorado. Every bar is a state, most expensive first. Pick one to see its carriers and full range.

Delaware $2,754 · 49th of 51
AK $6,026CO $1,820

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.